Table 1 Study characteristics of participants and study associations
From: Ocular complications in HIV positive patients on antiretroviral therapy in Ghana
Characteristics | Number of participants, n (%) | Number with HIV-related ocular complications, n (%) | p-value* | |
|---|---|---|---|---|
Age group (years) | 20 ≤ 30 | 16 | 7 (15) | 0.005 |
31 ≤ 45 | 60 | 27 (56) | ||
>45 | 24 | 14 (29) | ||
Gender | Male | 32 | 15 (31) | 0.479 |
Female | 68 | 33 (69) | ||
HIV Type | 1 | 90 | 42 (88) | 0.074 |
2 | 7 | 5 (10) | ||
1&2 | 3 | 1 (2) | ||
WHO Clinical Staging | 1 | 2 | 2 (4) | <0.001 |
2 | 23 | 8 (17) | ||
3 | 72 | 37 (77) | ||
4 | 3 | 1 (2) | ||
Ranges of CD4+ T Counts (cells/μL) | 0 ≤ 200 | 36 | 24 (50) | 0.001 |
201 ≤ 500 | 46 | 14 (29) | ||
> 500 | 18 | 10 (21) | ||
Adherence to Treatment | Regular | 74 | 21 (44) | 0.001 |
Irregular | 3 | 3 (6) | ||
Defaulting | 23 | 24 (50) | ||
Antiretroviral Regimen | 1st choice | 75 | 40 (83) | <0.001 |
2nd choice | 25 | 8 (17) | ||